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This negative report, based on statistical analysis of three distinct groups,
contradicts some previously-held conclusions in the field of hypertension.—Ed.

Angiotensin Infusion:
A Clinical Evaluation as a Screening Test for Renovascular Hypertension
By Ramon Berguer, M . D . * and Roger F. Smith, M . D . * *

Introduction
In 1963 Kaplan and Silah' suggested that hypertensive patients could be classified
according to their blood pressure response to an infusion of angiotensin I I . They
reported a lower pressor response in patients having renovascular hypertension than
in those having hypertension of the so-called essential type.'' The physiological
rationale for this test has been enunciated as follows: patients with hypertension
secondary to renal artery stenosis are expected to have high levels of endogenous
angiotensin because of their high renin output. Either due to saturation of the
end-organ with large amounts of endogenous angiotensin or due to elevated titers of
angiotensinases, little effect is to be expected from the injection of exogenous angiotensin I I . The blood pressure response in renovascular hypertensives to an infusion
of angiotensin, therefore, should be small.
Later work in this field revealed that the lesser type of response was also
observed in patients with malignant hypertension and in other conditions associated
with secondary hyperaldosteronism. A number of published papers dealing with the
pressor response to angiotensin infusion present contradictory observations and conclusions as to its clinical usefulness as a screening test.'-^' We undertook the present
study in an attempt to verify whether the angiotensin infusion test could be of value
in separating patients with renovascular hypertension from patients with other types
of non-malignant hypertension.
•Resident, Department of General Surgery.
**Chief of Division II, Department of General Surgery.
This study was aided in part by a grant of the Michigan Heart Association.
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Table I
Case Material
Groups
I (renovascular)
II (essenti. hypert.)
I l l (control)

No. of patients

Age (mean and s.d.
values)

6

53.7 ± 7.3
51.9 ± 8.3
20.6 ± 6.2

14

Materials and Methods
As shown in Table I , three groups of patients were studied. Group 1 included
six renovascular hypertensives. A l l six patients had established diastolic hypertension
(basal diastolic pressure greater than 90 mm Hg), stenosis of the renal artery or
arteries proved by arteriography and, later on, successful arterioplasties with good
clinical results (Figs. 1, 2 and 3).
Group 2 was formed by 13 hypertensives in whom clinical and radiological data
could rule out a specific etiology. Sixty percent of them had arteriograms confirming
the negative results of routine rapid sequence I V U and ' ^ ' I renograms. None of
the patients in group 1 or 2 had malignant hypertension or evidence of secondary
hyperaldosteronism.
Group 3 was the control group. It was formed by 14 young people without
hypertension or evidence of any other disease.
I 131 RENOGRAM

10
MIN.
Figure 1
Renovascular hypertension. Typical " i j renogram showing delayed pick-up in the left kidney tracing.
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1 MIN
Figure 2
Same patient as in Fig. 1. Typical rapid sequence I V U demonstrating delayed function in the left
kidney.

12 D A Y S
POST-OP
Figure 3
Same patient as in Fig. 1. Preoperative arteriogram showing the left renal artery stenosis and
postoperative arteriogram showing patent aortorenal bypass.
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The following method of infusion was followed: No medicamentous restrictions
were made. The patients were placed at basal conditions. An intravenous drip of
saline was started in an antecubital vein and basal blood pressures were recorded
every five minutes for a period of 25 minutes. At the end of the basal readings
the patients were infused 4 nanograms/kilogram/minute of angiotensin I I over a
five-minute period. The diastolic pressures were then recorded from the beginning
of the infusion every minute for six minutes. The patients received a mean of 160
ml of saline prior to the angiotensin infusion.
The lowest diastolic reading obtained during the basal blood pressure determinations was considered to be the basal diastolic pressure. The difference between
the highest diastolic reading during the infusion and the basal diastolic pressure was
interpreted as the maximal diastolic increment observed following the standard infusion
dose of angiotensin I I .
Kaplan and Silah reported no alterations in the pressor response to angiotensin
in patients receiving oral reserpine, hydralazine, guanethidine or alpha-methyldopa."
To rule out salt depletion as a factor of error, patients in whom a diastolic increment
of 20 mm Hg was not obtained were given 250-300 ml of saline and reinfused. Only
two instances of a moderately higher diastolic increment were observed in this study
following reinfusion after 250-300 ml of saline. This increase did not significantly
affect the statistical analysis of the groups. Therefore our data refer to the standard
infusion of 4 nanograms/kilogram/minute in all patients. Our results agree with
other workers using patients with normal salt intake and not on diuretics.^
Results
The maximal diastolic increment recorded following the angiotensin infusion
was determined for each patient. The mean and standard deviation values of this
increment were computed for each group as shown in Table I I . It is obvious that
there is an overlap in the response of the three groups. As has been previously observed,
the mean value is higher among the essential hypertensives (26.8) than in the renovascular group (25.0). However the standard deviation of group 1 is wide enough to
include the entire range of distribution of group 2, as shown graphically in Fig. 4.
The significance of the difference in the response of the three groups is shown
in Table I I I .
Table I I
Maximal diastolic increment during angiotensin infusion.
Group
I
11
111

Mean value
(mm Hg)

St. deviation

25.0
26.8
23.0

=tl6.6
±12.5
± 8.2
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Table I I I
P values obtained by comparison of the 3 groups
Group 2
Group 3
Group 3

versus
versus
versus

Group 1
Group 1
Group 2

:
:
:

0.82
0.80
0.36

It is meaningful that the highest value of P occurs when the values of group 1
are compared with those of group 2, precisely the two groups that need to be
separated.
Because of the small size of the samples involved the diastolic increment within
each group, and that of the three groups, were submitted to WeibuU statistical analysis.
Concerning the pressor response to angiotensin, there was a 95% confidence difference between the basal and the maximal diastolic readings in the renovascular and control
groups (Figs. 5A and 5C). In the essential hypertensive group there was overlap
in the response among those patients who had initial high basal diastolic readings
(Fig. 5B).
Simultaneous plotting of the pressor response in the three groups shows a unimodal
distribution for group 3. This we would expect from a control population. Group 1
(renovascular) is rather homogeneous with the exception of one value (the possibility
of this being a false value can be considered). The essential hypertension group is
irregular and heterogeneous and its plotting crosses the renovascular group making
their distinction impossible (Fig. 6).
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Figure 4
Diagram showing the maximal diastolic increment to the angiotensin infusion in each group.
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Figure 5
Weibull plotting of the basal and of the maximal diastolic infusion values for (A) renovascular group,
(B) essential hypertension group and (C) control group (P,, = basal diastolic value; P„ = maximal
diastolic value).
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Figure 6
WeibuU plotting of the pressor response of each of the three groups to the angiotensin infusion
(x = maximal diastoUc increment to the angiotensin infusion).

Discussion
It is commonly admitted that renovascular hypertensives have increased plasma
levels of renin and angiotensin. The pressor effect of the latter is believed to be
responsible for the hypertension of these patients. The renin-angiotensin pressor
mechanism is thought by many to be a pathological manifestation occurring within
a larger physiological set: the renin-angiotensin-aldosterone system, whose main action
is thought to be the maintenance of an adequate blood volume.' Admittedly all steps
are not clear and other factors must be implicated to explain the absence of hyperaldosteronism in a significant number of patients with renovascular hypertension or
the existence of a paradox such as Bartter's syndrome where hyperplasia of the
juxtaglomerular apparatus, increase in angiotensin levels, and hyperaldosteronism coexist with a normal blood pressure.
The mechanisms of renovascular hypertension may not be so simple. The
participation of the renomeduUary prostaglandins in renocortical ischemia and sub133
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sequent hypertension is yet to be determined. Another factor to be taken into account
concerning the pressor effect of angiotensin is that it increases the levels of circulating
catecholamines, with epinephrine increased more than norepinephrine." In spite of
these unanswered problems there is seemingly enough evidence to indicate that
increased production of angiotensin is a responsible factor in renovascular hypertension.
The theory behind the angiotensin infusion test implies that the angiotensin
effect is specific. But this assumption can also be challenged. It has been reported
that renovascular hypertensives have a lesser response to phenyllysine vasopressin
than do essential hypertensives.' Much the same response is assumed to occur with
angiotensin infusion. In either of these two groups we have not found a statistically
significant difference between the responses to a cold pressor test and to an angiotensin
infusion." On the other hand there is evidence for qualitatively different responses
to an infusion of angiotensin in the smooth muscle fibers of digital vessels among
essential hypertensives, renovascular hypertensives and normal subjects.^ Contradictory
effects following stimulation of the renin-angiotensin system have been postulated by
other authors.'
The pressor response that follows the injection of angiotensin is the algebraic
sum of different factors. In view of the complexity and lack of precise definition of
the action of angiotensin it is not surprising that we were not able to demonstrate in
our series a consistent differential pattern of response.
Three possible objections to our method of study were considered and found
insignificant for the following reasons: (i) the uniformity in the response of the
control group could serve as evidence for the uniformity of the pressor stimulus used;
(ii) the difference in mean age between the control and the other two groups is
considerable but the conclusions of this paper can be drawn by statistical analysis of
groups 1 and 2 alone, and (iii) in contrast with other series, the renovascular group
includes only patients who had surgical cure of the renovascular hypertension at a
later date.
Summary and Conclusions
The pressor response to an infusion of angiotensin I I was studied in three groups
of patients (renovascular hypertensives, essential hypertensives and a control group).
Statistical analysis shows that the difference in pressor response among renovascular
and essential hypertensives does not allow for their separation into two different
groups. We conclude that under practical clinical circumstances angiotensin infusion
will not serve as an adequate screening test for the identification of renovascular
hypertension.
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